Gin Hwa Biotech Incorporation (TPEX:7806)
Taiwan · Delayed Price · Currency is TWD 60.90
0.00 (0.00%)
At close: Sep 2, 2026
TPEX:7806 Revenue
Gin Hwa Biotech Incorporation had revenue of 145.93M TWD in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to 535.88M. In the year 2025, Gin Hwa Biotech Incorporation had annual revenue of 538.65M with 23.80% growth.
Revenue (ttm)
535.88M
Revenue Growth
+23.80%
P/S Ratio
3.61
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.94B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 538.65M | 103.57M | 23.80% |
| Dec 31, 2024 | 435.08M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.